Tirthankar Patnaik overweight on IT, pharma stocks

Tirthankar Patnaik, Director - Institutional Research at Religare Capital Markets is overweight on IT and pharma stocks.
  • Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
Real-time Stock quotes, portfolio, LIVE TV and more.
GeStepAhead Travelcafe SME Special
moneycontrol.com

Home » News » Stocks Views

Dec 18, 2013, 11.20 AM | Source: CNBC-TV18

Tirthankar Patnaik overweight on IT, pharma stocks

Tirthankar Patnaik, Director - Institutional Research at Religare Capital Markets is overweight on IT and pharma stocks.

Like this story, share it with millions of investors on M3

Tirthankar Patnaik overweight on IT, pharma stocks

Tirthankar Patnaik, Director - Institutional Research at Religare Capital Markets is overweight on IT and pharma stocks.

Post Your Comments

Share Cancel

Tirthankar Patnaik (more)

India Strategist, Mizuho Bank | Capital Expertise: Equity - Fundamental

Tirthankar Patnaik, Director - Institutional Research at Religare Capital Markets told CNBC-TV18, "Until we see clarity on inflation the portfolio positioning will remain guarded and defensive. So we remain overweight on IT. We have remained overweight on quality in general, but IT, pharma are our overweights."

He further added, "On financials, while we are talking about a peaking on rates we remain very concerned on asset quality. We don't know if the ramifications have really worked out in the system. So we would not be positive on financials at least until we see Q3 earnings come out. We remain underweight on financials. We are neutral on telecom and metals while marginally positive on consumer durables and negative on consumer staples."

"So all in all a defensive quality focused portfolio which might trail the benchmark if market does move meaningfully from current levels, but would stand us in good state if inflation does prove as chronic as we feel it would be," Patnaik said.

Ads by Google

Buy, Hold, Sell ? Hear it first on M3
Tirthankar Patnaik overweight on IT, pharma stocks

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login